For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of RXO Inc (NYSE: RXO) was $15.87 for the day, up 0.95% from the previous closing price of $15.72. In other words, the price has increased by $0.95 from its previous closing price. On the day, 1.43 million shares were traded. RXO stock price reached its highest trading level at $15.98 during the session, while it also had its lowest trading level at $15.61.
Ratios:
Our analysis of RXO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.30 and its Current Ratio is at 1.30. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.37.
On March 13, 2025, Truist started tracking the stock assigning a Buy rating and target price of $24.
On March 07, 2025, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $19.Deutsche Bank initiated its Hold rating on March 07, 2025, with a $19 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 14 ’25 when Szlosek Thomas A bought 7,500 shares for $16.65 per share. The transaction valued at 124,875 led to the insider holds 16,200 shares of the business.
Szlosek Thomas A bought 8,700 shares of RXO for $125,354 on May 09 ’25. The Director now owns 8,700 shares after completing the transaction at $14.41 per share. On Nov 12 ’24, another insider, Nettles Michelle, who serves as the Director of the company, bought 1,800 shares for $27.89 each. As a result, the insider paid 50,202 and bolstered with 15,185 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXO now has a Market Capitalization of 2601346816 and an Enterprise Value of 3270348800. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.51 while its Price-to-Book (P/B) ratio in mrq is 1.64. Its current Enterprise Value per Revenue stands at 0.645 whereas that against EBITDA is 26.588.
Stock Price History:
The Beta on a monthly basis for RXO is 1.58, which has changed by -0.39311665 over the last 52 weeks, in comparison to a change of 0.12463009 over the same period for the S&P500. Over the past 52 weeks, RXO has reached a high of $32.82, while it has fallen to a 52-week low of $12.19. The 50-Day Moving Average of the stock is 4.98%, while the 200-Day Moving Average is calculated to be -28.40%.
Shares Statistics:
RXO traded an average of 1.77M shares per day over the past three months and 1589590 shares per day over the past ten days. A total of 163.91M shares are outstanding, with a floating share count of 160.56M. Insiders hold about 2.05% of the company’s shares, while institutions hold 108.18% stake in the company. Shares short for RXO as of 1749772800 were 8730976 with a Short Ratio of 4.93, compared to 1747267200 on 7260584. Therefore, it implies a Short% of Shares Outstanding of 8730976 and a Short% of Float of 14.91.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
